X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR)

60 filings reported holding XFOR - X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share as of Q3 2025.
X4 Pharmaceuticals, Inc - Common Stock, par value $0.001 per share (XFOR) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 13.7M shares of 22.5M outstanding shares and own 60.76% of the company stock.
Largest 10 shareholders include Bain Capital Life Sciences Investors, LLC (2.44M shares), BVF INC/IL (2.23M shares), Nantahala Capital Management, LLC (2.23M shares), Rosalind Advisors, Inc. (1.54M shares), Deep Track Capital, LP (1.12M shares), Stonepine Capital Management, LLC (1.06M shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (933K shares), STEMPOINT CAPITAL LP (555K shares), VANGUARD GROUP INC (410K shares), and BOOTHBAY FUND MANAGEMENT, LLC (344K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.